Tenax Therapeutics | 8-K: Current report
Tenax Therapeutics | DEFA14A: Others
Tenax Therapeutics | 8-K: Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
Tenax Therapeutics | DEFA14A: Others
Tenax Therapeutics | DEF 14A: Definitive information statements
Tenax Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Tenax Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Tenax Therapeutics | 8-K: Current report
Tenax Therapeutics | 8-K: Current report
Tenax Therapeutics | 8-K: Current report
Tenax Therapeutics | 8-K: Current report
Tenax Therapeutics | 8-K: Current report
Tenax Therapeutics | 8-K: Current report
Tenax Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Tenax Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Tenax Therapeutics | 8-K: Current report
Tenax Therapeutics | 8-K: Current report
Tenax Therapeutics | 8-K: Current report
Tenax Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Tenax Therapeutics | 8-K: Current report
No Data